Whenever an excellent employee or leader leaves, it’s a blow to your organization.The departure of staff is an inevitable part of business, but in a fiercely competitive recruitment landscape like Japan, employee retention is a priority.Not only does retaining staff…
HOME > ORGANIZATION
ORGANIZATION
- KSLION to Stimulate Innovation in Life Science in Japan: Prof. Y. Natsumeda
March 5, 2012
- Generic Drug Share Reaches 23.6% in 3rd Quarter of FY2011: JGA
March 2, 2012
- EFPIA Japan Chairman Fauchet Says New Committee to Review Health Economic Assessment
March 1, 2012
- Daiichi-Sankyo, Eisai, Pfizer Japan Leaving Strongest Impression at Dispensing Pharmacies: NPhA Survey
February 29, 2012
- JPWA President Bessho Welcomes NPhA’s Efforts for Drug Distribution Improvement
February 29, 2012
- JPA Incumbent President Kodama Reelected as Next Term Candidate
February 28, 2012
- Sales by Member Companies Rose 5% in 2011: JCROA
February 28, 2012
- NPhA Refers Plan to Recommend Next President to Board Review
February 27, 2012
- Toshiki Iwasaki to Step Down as NPhA President in May
February 24, 2012
- JSCTR to Set Up“GCP Expert” Certification to Improve Quality of Clinical Studies
February 21, 2012
- Japan Pharmaceutical Political Association Chairman Kumakura to Focus on Resolving Price Difference
February 21, 2012
- Prof. Kimura of Saga Univ. Receives Top Award for Research on Ubiquilin 1 Inhibitor
February 17, 2012
- 12 Organizations from 11 Countries, Regions to Participate in Asian Cooperation Conference
February 16, 2012
- JPMA VP Nogimori Focused on Thorough Compliance, Promotion of International Cooperation
February 15, 2012
- KIF5B-RET Fusion Gene Identified as Potential Target in Pulmonary Adenocarcinoma
February 13, 2012
- NPhA Compiles Draft Proposal for Mutual Understanding to Improve Distribution
February 10, 2012
- MHLW “Missing the Bigger Picture” in Measures to Eliminate Drug Lag: Prof. Nakamura
February 10, 2012
- PhRMA Concerned that Health Economic Evaluation Will Be Used to Reduce NHI Prices: Mr Zulueta
February 6, 2012
- JACDS to Strengthen Support to Ensure Compliance in Sale of OTC Drugs
February 6, 2012
- It Is Difficult to Check Off-Label Use of Generics Approved for Indications Different from Those of Original Drugs: Medical Bill Payment Fund
February 1, 2012
ページ
On March 5, Japan unveiled new NHI prices for the FY2024 drug price revision. A Jiho survey found that Tsumura, a specialist in Japanese Kampo herbal medicines, received an astonishing raise of over 24% in its drug prices on a…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…